Reliability and Validity of Outcome Measures for Pain in Multiple Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-01

Study Completion Date

2024-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to provide values of test-retest reliability and insights from concurrent validity of outcome measures for pain in multiple sclerosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Physiological Responses in Experimentally Induced Cognitive Fatigue in People With Multiple Sclerosis (MS)

NCT05003375

Multiple Sclerosis Fatigue Stress

UNKNOWN

MR Spectroscopy as a Diagnostic and Outcome Measure in Pain and SCI

NCT00561782

Spinal Cord Injury Hyperalgesia, Secondary Hyperalgesic Sensations

COMPLETED

Individual Differences in Cognitive Control Predict Real-time fMRI Neurofeedback Performance

NCT07211269

Healthy

RECRUITING NA

Descriptive Pilot Study of the Effects of a Standardized Neuromodulation Program on Cortical Brain Function in Chronic Low Back Pain Patients

NCT03929952

Low Back Pain Chronic Low Back Pain

COMPLETED NA

Evaluation of the Brain Activity During Spinal Cord Stimulation in Failed Back Surgery Syndrome Using Functional MRI and MRS

NCT01181817

Failed Back Surgery Syndrome

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pain is one of the most annoying symptoms in multiple sclerosis (MS). However, it is underestimated albeit its high prevalence rate with 63%. It negatively affects health related quality of life, activity of daily living, mental health, social functioning, employment, sleep and life enjoyment. In literature, the prevalence of pain varies in the MS literature from 29% to 86%. This wide-range prevalence is the result of methodological differences and non-uniformity of the studied populations which makes pain unclear and underdiagnosed in multiple sclerosis.It is hypothesized that the consistency, severity and interference of pain have varying relationships between other factors such as depression, anxiety, sleep or fatigue.

Evaluating pain was done with various outcome measures resulting in inconclusive results. However, very few of the pain outcome measures are validated for MS population. Thus, it cannot be advised yet whether they contain similar or complementary information. Finally, the interference of pain on activities and participation level of the International Classification of Functioning, Disability and Health (ICF) is poorly documented.

This project aims to put the foundations for future interventional research by providing values of test-retest reliability and insights from concurrent validity. As well, the perceived interference from pain on activities and participation level will be documented.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 and above,
* Ambulatory pwMS with definite diagnosis based on McDonald criteria
* Expanded Disability Status Scale of 6.0 or below,
* Having pain in last month
* Able to understand and answer the questions in the questionnaires.

Exclusion Criteria

* Diagnosed with major musculoskeletal disorder and any neurological disorder other than MS,
* a relapse in the last month before enrolment,
* cognitive decline that renders the patient incapable of performing tests and questionnaires,
* patients with only headache

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No